학술논문

Corrigendum to 'VP1-2021: Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer': Annals of Oncology 2021;32:574-575.
Document Type
Correction Notice
Source
Annals of Oncology. Jun2021, Vol. 32 Issue 6, p820-820. 1p.
Subject
*DRUG efficacy
*EVEROLIMUS
*BREAST cancer treatment
Language
ISSN
0923-7534